Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$160.0M
+190.1% from 2023
Prescriptions
4,023
$39,777.92 per claim
Patients
547
547 prescribers
Total spending, 2024
$160.0M
$292,553.18 per patient
Medicare prescription drug plans paid $160.0M for Ayvakit in 2024, for 4,023 prescriptions and refills to 547 patients (up 190.1% from 2023). The average cost per claim was $39,777.92.
California had the highest Medicare cost for Ayvakit in 2024: $17.1M for 410 claims, followed by New York ($14.0M).
William Robinson, medical oncology in Aurora, CO, had the highest Medicare cost for Ayvakit in 2024: 75 claims costing $3.2M.
Ayvakit is made by Sanofi (SNY), listed in the Medicare spending data as Blueprint Medic.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| William Robinson Aurora, CO | Medical Oncology | 75 | Under 11 | $3.2M |
| Elizabeth O Hexner Philadelphia, PA | Hematology-Oncology | 75 | Under 11 | $3.1M |
| Kristen M Pettit |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 181 | 880 | 156 | $32.3M |
| 2023 | 288 | 1,398 | 267 | $55.2M |
| 2024 | 547 | 4,023 | 547 | $160.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology |
| 73 |
| Under 11 |
| $3.0M |
| Anthony Hunter Atlanta, GA | Hematology | 51 | Under 11 | $2.0M |
| Andrew T Kuykendall Tampa, FL | Internal Medicine | 51 | Under 11 | $2.0M |
| Daniel J Deangelo Boston, MA | Medical Oncology | 51 | Under 11 | $2.0M |
| Elizabeth A Griffiths Buffalo, NY | Hematology-Oncology | 32 | Under 11 | $1.8M |
| Cecilia Y Arana Yi Scottsdale, AZ | Hematology-Oncology | 40 | Under 11 | $1.6M |
| Robert F Manges Fort Wayne, IN | Medical Oncology | 24 | Under 11 | $1.5M |
| Pankit J Vachhani Birmingham, AL | Hematology-Oncology | 38 | Under 11 | $1.4M |
| Tsewang Tashi Salt Lake City, UT | Hematology-Oncology | 37 | Under 11 | $1.4M |
| Abdulraheem Yacoub Westwood, KS | Hematology-Oncology | 33 | Under 11 | $1.3M |
| Ahmed Al-Hazzouri Clermont, FL | Medical Oncology | 11 | Under 11 | $1.2M |
| Paul C Hendrie Seattle, WA | Hematology | 25 | Under 11 | $1.2M |
| Marin F Xavier San Diego, CA | Hematology-Oncology | 22 | Under 11 | $1.2M |
| Ruchi J Desai Richmond, VA | Hematology-Oncology | 29 | Under 11 | $1.1M |
| James K McCloskey II Hackensack, NJ | Hematology-Oncology | 33 | Under 11 | $1.1M |
| Vikas Bhushan Dallas, TX | Hematology-Oncology | 28 | Under 11 | $1.1M |
| Candido E Rivera-Linares Jacksonville, FL | Hematology-Oncology | 27 | Under 11 | $1.1M |
| Zohra I Nooruddin San Antonio, TX | Medical Oncology | 27 | Under 11 | $1.0M |
| Lloyd Damon San Francisco, CA | Hematology | 28 | Under 11 | $994K |
| H J Wedner Saint Louis, MO | Allergy/ Immunology | 23 | Under 11 | $978K |
| Stephen T Oh Saint Louis, MO | Hematology | 24 | Under 11 | $906K |
| Ashwin Kishtagari Nashville, TN | Hematology | 23 | Under 11 | $906K |
| Timothy E Kubal Tampa, FL | Hematology-Oncology | 23 | Under 11 | $888K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Blueprint Medic SNY | 4,023 | $160.0M |